AZTA

MKT CAP:$1B

Azenta, Inc.

Market Cap

$1B

Healthcare·Medical - Instruments & Supplies·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$26.28-$7.11 (-21.29%)

Apr 21, 2026

Company Details

Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life S...

CEO

John Marotta

IPO Date

Feb 2, 1995

Website

www.azenta.com

Key Metrics TTM

Revenue

$599M

+0.8% YoY

Net Income

-$28M

EPS (Diluted)

-$0.76

Free Cash Flow

$46M

Revenue / Share

$13.05

Gross Margin

45.5%

Operating Margin

-0.7%

Net Margin

-4.7%

FCF Margin

7.7%

P/S

2.0x

P/E

—

Earnings Reports

Q2 2026

May 6, 2026

PENDING

Q1 2026

Feb 5, 2026

$149M+0.8%EPS -$0.34

FY 2025

Dec 4, 2025

$594M+3.6%EPS -$1.22

Q4 2025

Dec 4, 2025

$159MEPS $1.02

Q3 2025

Aug 6, 2025

$144M-0.2%EPS -$1.15

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q4 20	$108M	$46M	$232.0K
Q1 21	$118M	$50M	$317.0K
Q2 21	$130M	$51M	-$9M
Q3 21	$129M	$55M	-$883.0K
Q4 21	$137M	$59M	$881.0K
Q1 22	$140M	$61M	-$152.0K
Q1 23	$178M	$66M	-$26M
Q2 23	$148M	$46M	-$28M
Q4 23	$172M	$61M	-$15M
Q1 24	$142M	$56M	-$15M
Q2 24	$136M	$61M	-$12M
Q3 24	$144M	$65M	-$4M
Q1 25	$147M	$69M	-$4M
Q3 25	$144M	$68M	$2M
Q4 25	$159M	$72M	$3M
Q1 26	$149M	$64M	-$5M

Valuation

Quarter	P/S	P/E
Q4 20	4.5x	52.6x
Q1 21	8.3x	70.8x
Q2 21	10.0x	62.1x
Q3 21	14.9x	61.2x
Q4 21	15.8x	73.3x
Q1 22	14.5x	60.8x
Q1 23	7.2x	45.0x
Q2 23	4.7x	57.6x
Q4 23	4.4x	92.4x
Q1 24	5.6x	—
Q2 24	5.2x	—
Q3 24	4.2x	—
Q1 25	4.0x	—
Q3 25	2.5x	—
Q4 25	2.2x	—
Q1 26	2.7x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 20	$52M	$42M
Q1 21	$44M	$29M
Q2 21	$34M	$24M
Q3 21	$45M	$36M
Q4 21	$27M	$9M
Q1 22	$16M	-$3M
Q1 23	-$27M	-$40M
Q2 23	-$12M	-$21M
Q4 23	$40M	$30M
Q1 24	$14M	$2M
Q2 24	$9M	$364.0K
Q3 24	$10M	$1M
Q1 25	$30M	$22M
Q3 25	$26M	$15M
Q4 25	$2M	-$6M
Q1 26	$21M	$15M

Capital Expenditures

Quarter	CapEx
Q4 20	$10M
Q1 21	$15M
Q2 21	$10M
Q3 21	$9M
Q4 21	$18M
Q1 22	$18M
Q1 23	$13M
Q2 23	$9M
Q4 23	$10M
Q1 24	$11M
Q2 24	$8M
Q3 24	$8M
Q1 25	$8M
Q3 25	$11M
Q4 25	$8M
Q1 26	$6M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 20	-46.9%	-42.3%
Q1 21	-43.9%	-39.0%
Q2 21	-41.2%	-32.3%
Q3 21	-41.4%	-35.2%
Q4 21	+26.5%	+26.0%
Q1 22	+18.2%	+18.7%
Q1 23	+37.7%	+47.4%
Q2 23	+15.0%	+36.0%
Q4 23	+25.9%	+37.4%
Q1 24	+1.5%	+12.4%
Q2 24	-23.6%	-27.5%
Q3 24	-2.8%	-16.0%
Q1 25	-14.5%	-19.2%
Q3 25	+1.6%	-9.4%
Q4 25	+16.7%	+5.3%
Q1 26	+3.0%	+3.4%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 20	$4M	3.7%
Q1 21	$7M	5.7%
Q2 21	$7M	5.8%
Q3 21	$6M	4.7%
Q4 21	$7M	5.2%
Q1 22	$8M	5.7%
Q1 23	$2M	1.2%
Q2 23	$4M	2.7%
Q4 23	-$715.0K	-0.4%
Q1 24	$3M	2.3%
Q2 24	$6M	4.1%
Q3 24	$4M	2.6%
Q1 25	$5M	3.5%
Q3 25	$2M	1.7%
Q4 25	$5M	3.1%
Q1 26	$4M	2.7%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 20	$4M	$41M
Q1 21	$5M	$45M
Q2 21	$5M	$55M
Q3 21	$5M	$50M
Q4 21	$7M	$51M
Q1 22	$6M	$54M
Q1 23	$8M	$85M
Q2 23	$9M	$66M
Q4 23	$9M	$66M
Q1 24	$7M	$64M
Q2 24	$8M	$65M
Q3 24	$7M	$63M
Q1 25	$7M	$65M
Q3 25	$7M	$59M
Q4 25	$8M	$61M
Q1 26	$9M	$59M

Revenue Segments

Quarter	Products	Services	Product	Service
Q1 22	$46M	$94M	—	—
Q1 23	—	—	$86M	$93M
Q2 23	—	—	$52M	$96M
Q4 23	—	—	$72M	$100M
Q1 25	—	—	$44M	$104M
Q3 25	—	—	$39M	$105M
Q4 25	—	—	$48M	$111M
Q1 26	—	—	$41M	$108M

Revenue by Geography

Quarter	Asia Pacific, Other than China	Europe	North America	Africa	China	United Kingdom	Asia Pacific
Q1 22	$21M	$29M	$90M	—	—	—	—
Q1 23	$14M	$39M	$89M	$17M	$13M	$5M	—
Q2 23	$13M	$21M	$87M	$9M	$12M	$6M	—
Q4 23	$14M	$25M	$92M	$20M	$14M	$7M	—
Q1 25	—	$24M	$93M	—	$15M	$8M	$7M

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 22	$1.9B	$817M	$2.8B
Q3 22	$1.5B	$709M	$2.2B
Q4 22	$658M	$912M	$1.6B
Q1 23	$615M	$523M	$1.1B
Q2 23	$671M	$514M	$1.2B
Q3 23	$733M	$390M	$1.1B
Q4 23	$679M	$339M	$1.0B
Q1 24	$703M	$281M	$984M
Q2 24	$357M	$468M	$825M
Q3 24	$339M	$259M	$599M
Q4 24	$311M	$151M	$462M
Q1 25	$377M	$86M	$463M
Q2 25	$254M	$75M	$328M
Q3 25	$270M	$49M	$319M
Q4 25	$282M	$61M	$343M
Q1 26	$339M	$73M	$412M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q4 20	74M	+0.2%	+2.1%
Q1 21	74M	+0.4%	+0.9%
Q2 21	74M	-0.0%	+0.6%
Q3 21	74M	+0.0%	+0.6%
Q4 21	75M	+0.3%	+0.7%
Q1 22	75M	+0.4%	+0.8%
Q1 23	73M	-3.1%	-2.3%
Q2 23	69M	-4.7%	-7.0%
Q4 23	60M	-13.6%	-19.9%
Q1 24	57M	-5.0%	-24.3%
Q2 24	55M	-2.2%	-23.6%
Q3 24	53M	-4.5%	-23.4%
Q1 25	46M	-13.9%	-23.6%
Q3 25	46M	+0.2%	-19.4%
Q4 25	46M	+0.6%	-17.0%
Q1 26	46M	-0.1%	-13.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q4 20	$34.3K	3K
Q1 21	$37.4K	3K
Q2 21	$41.0K	3K
Q3 21	$40.9K	3K
Q4 21	$47.2K	3K
Q1 22	$48.2K	3K
Q1 23	$55.7K	3K
Q2 23	$46.4K	3K
Q4 23	$49.2K	4K
Q1 24	$40.5K	4K
Q2 24	$39.0K	4K
Q3 24	$41.2K	4K
Q1 25	$44.7K	3K
Q3 25	$43.6K	3K
Q4 25	$53.1K	3K
Q1 26	$49.5K	3K

Revenue / Employee